R. Scragg et al., SERUM 25-HYDROXYCHOLECALCIFEROL CONCENTRATION IN NEWLY DETECTED HYPERTENSION, American journal of hypertension, 8(4), 1995, pp. 429-432
Although blood concentrations of the active metabolite 1,25-dihydroxyv
itamin D are raised in hypertension, concentrations of 25-hydroxyvitam
in D, the main vitamin D metabolite, do not appear to have been report
ed in newly detected hypertension. Serum levels of 25-hydroxycholecalc
iferol were measured in 186 newly detected hypertensive patients (bloo
d pressure > 160/95 mm Hg and never on antihypertensive medication) an
d normotensive controls individually matched by sex, age (+/- 2 years)
, ethnicity, and date of interview. Serum 25-hydroxycholecalciferol le
vels were similar in cases (mean (SD) = 64 (21) nmol/L) and controls (
67 (28) nmol/L, P = .20), We conclude that serum 25-hydroxycholecalcif
erol, a marker of body vitamin D, is normal in hypertension.